Daniela Drandi

3.4k total citations
45 papers, 1.5k citations indexed

About

Daniela Drandi is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology. According to data from OpenAlex, Daniela Drandi has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pathology and Forensic Medicine, 21 papers in Genetics and 16 papers in Hematology. Recurrent topics in Daniela Drandi's work include Lymphoma Diagnosis and Treatment (23 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Multiple Myeloma Research and Treatments (14 papers). Daniela Drandi is often cited by papers focused on Lymphoma Diagnosis and Treatment (23 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Multiple Myeloma Research and Treatments (14 papers). Daniela Drandi collaborates with scholars based in Italy, United States and Germany. Daniela Drandi's co-authors include Marco Ladetto, Mario Boccadoro, Antonio Palumbo, Simone Ferrero, Reinhold Munker, Rami I. Aqeilan, Tiziana Palumbo, Cristian Taccioli, Michael Kuehl and Nicola Zanesi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Daniela Drandi

44 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Drandi Italy 16 702 593 458 435 427 45 1.5k
Venkata Yellapantula United States 9 610 0.9× 874 1.5× 223 0.5× 163 0.4× 437 1.0× 25 1.5k
Manoj Raghavan United Kingdom 17 734 1.0× 910 1.5× 257 0.6× 157 0.4× 267 0.6× 45 1.7k
Violaine Havelange Belgium 17 769 1.1× 678 1.1× 558 1.2× 181 0.4× 525 1.2× 46 1.7k
Kourong Miao China 17 560 0.8× 202 0.3× 260 0.6× 197 0.5× 385 0.9× 79 1.1k
Nadine Carbuccia France 19 749 1.1× 841 1.4× 231 0.5× 205 0.5× 222 0.5× 35 1.5k
B. Douglas Smith United States 13 899 1.3× 834 1.4× 776 1.7× 117 0.3× 214 0.5× 23 1.6k
Monica Messina Italy 20 803 1.1× 503 0.8× 581 1.3× 1.1k 2.5× 393 0.9× 49 2.2k
Andrés Jerez Spain 17 639 0.9× 793 1.3× 210 0.5× 358 0.8× 167 0.4× 60 1.6k
Domenica Ronchetti Italy 23 1.2k 1.8× 578 1.0× 340 0.7× 176 0.4× 616 1.4× 54 1.6k
Tony G. Willis United Kingdom 13 675 1.0× 186 0.3× 526 1.1× 890 2.0× 404 0.9× 17 1.8k

Countries citing papers authored by Daniela Drandi

Since Specialization
Citations

This map shows the geographic impact of Daniela Drandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Drandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Drandi more than expected).

Fields of papers citing papers by Daniela Drandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Drandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Drandi. The network helps show where Daniela Drandi may publish in the future.

Co-authorship network of co-authors of Daniela Drandi

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Drandi. A scholar is included among the top collaborators of Daniela Drandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Drandi. Daniela Drandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kapoor, Prashant, Meletios Α. Dimopoulos, Stephen M. Ansell, et al.. (2025). Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease. Seminars in Hematology. 62(2). 90–105. 1 indexed citations
2.
Drandi, Daniela, et al.. (2023). MYD88 L265P Mutation Detection by ddPCR: Recommendations for Screening and Minimal Residual Disease Monitoring. Methods in molecular biology. 2621. 57–72. 2 indexed citations
3.
Dogliotti, Irene, Davide Bertuzzo, Giulia Benevolo, et al.. (2022). Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up. European Journal of Neurology. 29(12). 3611–3622. 9 indexed citations
4.
Vitale, Candida, Valentina Griggio, Daniela Drandi, et al.. (2022). Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights. Frontiers in Oncology. 12. 917115–917115. 3 indexed citations
5.
Drandi, Daniela, et al.. (2022). Nucleic Acid Biomarkers in Waldenström Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance. Diagnostics. 12(4). 969–969. 7 indexed citations
6.
Castellino, Alessia, Claudia Castellino, Margherita Bonferroni, et al.. (2020). Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports. Journal of Medical Case Reports. 14(1). 75–75. 6 indexed citations
7.
Drandi, Daniela, Simone Ferrero, & Marco Ladetto. (2018). Droplet Digital PCR for Minimal Residual Disease Detection in Mature Lymphoproliferative Disorders. Methods in molecular biology. 1768. 229–256. 20 indexed citations
8.
Gambella, Manuela, Paola Omedè, Stefania Oliva, et al.. (2014). In Multiple Myeloma, Minimal Residual Disease (MRD) Is an Early Predictor of Progression and Is Modulated By Maintenance Therapy with Lenalidomide. Blood. 124(21). 3394–3394. 2 indexed citations
9.
Ferrero, Simone, Luigia Monitillo, Barbara Mantoan, et al.. (2013). Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. Annals of Hematology. 92(11). 1503–1511. 10 indexed citations
10.
Ladetto, Marco, Monika Brüggemann, Luigia Monitillo, et al.. (2013). Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders. Leukemia. 28(6). 1299–1307. 218 indexed citations
11.
Rinaldi, Andrea, Michael Mian, Ivo Kwee, et al.. (2011). Genome‐wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia. British Journal of Haematology. 154(5). 590–599. 25 indexed citations
12.
Coscia, Marta, Francesca Pantaleoni, Chiara Riganti, et al.. (2011). IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells. Leukemia. 25(5). 828–837. 56 indexed citations
13.
Ladetto, Marco, G Pagliano, Simone Ferrero, et al.. (2010). Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma. Journal of Clinical Oncology. 28(12). 2077–2084. 181 indexed citations
14.
Ricca, Irene, Alberto Rocci, Daniela Drandi, et al.. (2007). Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients. Leukemia. 21(4). 697–705. 33 indexed citations
15.
Majolino, Ignazio, Marco Ladetto, Anna Locasciulli, et al.. (2006). High-Risk Fludarabine-Pretreated B-Cell Chronic Lymphocytic Leukemia's High Response Rate Following Sequential DHAP and Alemtuzumab Administration Though in Absence of Molecular Remission. Medical Oncology. 23(3). 359–368. 3 indexed citations
16.
Ladetto, Marco, Michele Magni, G Pagliano, et al.. (2006). Rituximab Induces Effective Clearance of Minimal Residual Disease in Molecular Relapses of Mantle Cell Lymphoma. Biology of Blood and Marrow Transplantation. 12(12). 1270–1276. 43 indexed citations
17.
Ladetto, Marco, Mara Compagno, Irene Ricca, et al.. (2004). Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders. Blood. 103(12). 4644–4649. 30 indexed citations
18.
Ladetto, Marco, Barbara Mantoan, Irene Ricca, et al.. (2003). Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma clone. Experimental Hematology. 31(9). 784–788. 9 indexed citations
19.
Ladetto, Marco, Paola Omedè, John W. Donovan, et al.. (2002). Real-time polymerase chain reaction in multiple myeloma. Experimental Hematology. 30(6). 529–536. 15 indexed citations
20.
Ladetto, Marco, Monica Astolfi, Paolo Corradini, et al.. (2001). Central Nervous System Relapse in a Patient with Mantle Cell Lymphoma in Continuous Clinical and Molecular Remission at Six Years Since Autografting. Leukemia & lymphoma. 40(5-6). 679–682. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026